• 1
    Circulaire 98/228 of April, 9th 1998 relating to the recommendations of implementation of a antiretroviral treatment after exposure to the risk of transmission of HIV, French Ministry of Employment and Solidarity, 1998.
  • 2
    Centers for Disease Control. Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. 2005. Report No.: 54 (No. RR-2).
  • 3
    World Health Organization (WHO). Post-Exposure Prophylaxis to Prevent HIV Infection: Joint WHO/ILO Guidelines on Post-Exposure Prophylasis (PEP) to Prevent HIV Infection. Geneva, WHO, 2007.
  • 4
    Secretaria del Plan Nacional sobre el SIDA. Recomendaciones de la SPNS/GESIDA/AEP/CEEISCAT/SEMP sobre la profilaxis postexposición frente al VIH, VHB Y VHC en adultos y niños. Ministerio de Sanidad y Política Social; 2008.
  • 5
    Bryant J, Baxter L, Hird S. Non-occupational postexposure prophylaxis for HIV: a systematic review. Health Technol Assess 2009; 13 (iii, ix-x): 160.
  • 6
    Martin JN, Roland ME, Neilands TB et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS 2004; 18: 787792.
  • 7
    Fitch JT, Stine C, Hager WD, Mann J, Adam MB, McIlhaney J. Condom effectiveness: factors that influence risk reduction. Sex Transm Dis 2002; 29: 811817.
  • 8
    Roland ME, Neilands TB, Krone MR et al. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis 2005; 41: 15071513.
  • 9
    Vives N, Almeda J, Contreras CA, Garcia F, Campins M, Casabona J. Use of non-occupational HIV post-exposure prophylaxis in Spain (2001–2005). Enferm Infecc Microbiol Clin 2008; 26: 546551.
  • 10
    Tissot F, Erard V, Dang T, Cavassini M. Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis. HIV Med 2010; 11: 584592.
  • 11
    Lunding S, Katzenstein TL, Kronborg G et al. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006. Sex Transm Dis 2010; 37: 4952.
  • 12
    Donnell D, Mimiaga MJ, Mayer K, Chesney M, Koblin B, Coates T. Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial. AIDS Behav 2010; 14: 11821189.
  • 13
    Poynten IM, Jin F, Mao L et al. Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men. AIDS 2009; 23: 11191126.
  • 14
    Mehta SA, Silvera R, Bernstein K, Holzman RS, Aberg JA, Daskalakis DC. Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect 2011; 87: 344348.
  • 15
    Liu AY, Kittredge PV, Vittinghoff E et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr 2008; 47: 241247.
  • 16
    Rey D, Bouhnik AD, Peretti-Watel P, Obadia Y, Spire B. Awareness of non-occupational HIV postexposure prophylaxis among French people living with HIV: the need for better targeting. AIDS 2007; 21 (Suppl 1): S71S76.
  • 17
    Almeda J, Allepuz A, Simon BG, Blasco JA, Esteve A, Barbara J. Non-occupational post-exposure HIV prophylaxis. Knowledge and practices among physicians and groups with risk behavior. Med Clin (Barc) 2003; 20: 321326.
  • 18
    Breslow NE, Day NE. Statistical methods in cancer research. Volume I – The analysis of case-control studies. IARC Sci Publ 1980;5338.
  • 19
    Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edn. New York, John Wiley & Sons Inc., 2000.
  • 20
    McCartney D, Bader M, Donlon S, Hickson F, Quinlan M. Real Lives 2: findings from the all-ireland gay men's sex surveys, 2005 and 2006. The Gay Men's Health Service, HSE and The Rainbow Project; 2009 Jun.
  • 21
    van der Snoek EM, de Wit JB, Mulder PG, van der Meijden WI. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis 2005; 32: 170175.
  • 22
    Hickson F, Weatherburn P, Rey D, Jessup K, Hammond G. Testing targets: findings from the United Kingdom Gay Men's Sex Survey 2007. Sigma Research; 2009 Sep.
  • 23
    Secretaría del Plan Nacional sobre el Sida. Plan Multisectorial frente al VIH y el sida. España 2008–2012. Available at (accessed 1 October 2012).